This April 21 In Focus webcast features an expert panel examining the new legislative landscape of the 112th Congress and what the current budget battles mean for U.S. global health programs.
- view as grid
- view as list
This fact sheet reviews current national and state policies around Emergency Contraception, including methods, patient awareness, access and availability, and insurance coverage. Among methods discussed are ulipristal acetate (including ella), copper IUDs (including Copper-T IUDs), and progestin-based pills (including Plan B, Next Choice,Levonorgestrel and Fallback Solo).
This budget analysis reviews U.S. funding for global health programs included in the fiscal year 2015 Budget Request released on March 4, 2014. It examines funding by program area as well as trends over time.
The report examines state Medicaid program policies regarding coverage of pregnancy-related services. It details state-level Medicaid eligibility and enrollment policies for pregnant women, as well as scope of coverage for prenatal and screening services, delivery and post-partum care, educational classes and support services.
This issue brief dissects the issues raised by the legal challenges to the Affordable Care Act’s requirement that private insurance plans include contraception as part of their coverage of preventive services for women. Over 40 for-profit corporations and over 40 nonprofit corporations have filed lawsuits claiming that the requirement to provide their employees with contraceptives violates their religious rights. On November 26, 2013, the Supreme Court agreed to hear two cases filed by for-profit corporations, Hobby Lobby and Conestoga Wood Specialties, that claim that this requirement violates their religious rights. At the crux of these cases is a question that the Supreme Court has not previously addressed: Do for-profit corporations have religious protections under the 1993 Religious Freedom Restoration Act and the First Amendment? The brief provides background on how the ACA’s contraceptive requirement works, summarizes some of the legal challenges brought by for-profit and non-profit organizations and discusses the implications of potential rulings by the Supreme Court.
The U.S. Government and International Family Planning & Reproductive Health: Statutory Requirements and Policies
This fact sheet summarizes the major statutory requirements and policies pertaining to U.S. global family planning/reproductive health (FP/RH) efforts over time and identifies those currently in effect.
This report presents state-by-state policies on coverage of key areas in reproductive health for low-income women, including contraception, preconception care, screenings for sexually transmitted diseases and coverage within special state Medicaid family planning programs.
This report establishes a baseline level of donor government funding for family planning activities in 2012 that can be used to track total international assistance funding levels for family planning over time as well as commitments donor governments made at last year’s London Summit on Family Planning. It finds donor governments provided about US$900 million in bilateral funding for family planning programs in 2012, and an additional US$432 million in core contributions to the United Nations Population Fund (UNFPA).
Women and Health Care in the Early Years of the ACA: Key Findings from the 2013 Kaiser Women’s Health Survey
This report addresses a wide range of topics that are at the heart of women’s health care, as well as changes that women may experience as a result of the Affordable Care Act (ACA). The findings in the report, based off a nationally representative survey conducted by the Kaiser Family Foundation, highlight differences in health care for uninsured, low-income, and minority women. Other focus areas include: coverage, access, and affordability; connections to health providers; access and utilization of preventive services; and reproductive and sexual health services for women of reproductive age, such as contraception and family planning services and screenings for sexually transmitted infections (STIs).